Arrhythmia Market Share, Size, Trends, Industry Analysis Report, By Type (Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias); By Site of Origin Atrial; By Test Equipment; By Region; Segment Forecast, 2022 - 2030
Description
The global arrhythmia market size is expected to reach USD 14.59 billion by 2034 according to a new study by Polaris Market Research. The report “Arrhythmia Market Share, Size, Trends, Industry Analysis Report, By Type (Supraventricular Tachycardias, Ventricular Arrhythmias, Bradyarrhythmias); By Site of Origin Atrial; By Test Equipment; By Region; Segment Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The introduction of technologically enhanced and innovative devices by the major players is driving the industry's growth. The industry's growth is likely to be aided by the development of technologically improved monitoring devices. Further, in July 2021, in the US, Abbott revealed Jot Dx, a new insertable cardiac monitor (ICM) designed to improve precise identification of difficult-to-detect irregular heart rhythms and reduce data burden. This technology allows for remote detection of cardiac arrhythmia and improves the accuracy of patient diagnosis.
Also, in March 2022, the ZOLL Arrhythmia Management System (AMS) from ZOLL Medical is a device that combines biometrics data with ECG data collected by typical mobile cardiac telemetry (MCT) devices. Over 60% of patients had their treatment plans changed once biometric data was added, including changes to lifestyle, drugs, and follow-up plans. Thus, these technologically advanced devices are boosting industry growth.
Based on the type, the tachycardia segment accounted for the leading share in the market. In the next years, the use of technologically enhanced solutions for disease monitoring is likely to boost demand for the tachycardia category. In 2021, atrial tachycardia accounted for the majority of the market and was predicted to continue to expand shortly.
It's a type of supraventricular tachycardia that needs to be treated aggressively for the best results. Cardiac-based devices serve an important role in improving illness detection and therapy. As a result of the rising risk of tachycardia, the cardiac market is expected to develop significantly shortly. Also, as per the CDC, around 40 Mn individuals in the U.S. still smoke, and 2.6 Mn school kids, including e-cigarette users. Every day, nearly 1,600 American teenagers under the age of 18 light up their 1st cigarette. Approximately 0.5 Mn people in the U.S. die prematurely each year. Another 16 million people suffer from a serious ailment as a result of smoking.
Market players such as Koninklijke Philips N.V., AliveCor, Biotronik, Biotricity, GE Healthcare, iRhythm Technologies, Medtronic plc., Nihon Kohden Corporation, St. Jude Medical (Abbott Laboratories), Spacelabs Healthcare (OSI Systems, Inc.), Applied Cardiac Systems, and Welch Allyn (Hillrom Services, Inc.) are some key players operating in the global market. In November 2021, Philips agreed to buy Cardiologs. This acquisition expands the company's cardiac monitoring and diagnostics product range, providing revenue growth potential in the industry.
Polaris Market Research has segmented the arrhythmia market report based on test equipment, site of origin atrial, type, and region:
Arrhythmia, Test Equipment Outlook (Revenue - USD Billion, 2020 - 2034)
Electrocardiogram (ECG)
Holter monitor
Arrhythmia, Site of Origin Atrial Outlook (Revenue - USD Billion, 2020 - 2034)
Sinus bradycardia
Premature atrial contractions (PACs)
Wandering atrial pacemaker
Atrial tachycardia
Multifocal atrial tachycardia
Supraventricular tachycardia (SVT)
Atrial flutter
Atrial fibrillation (Afib)
Arrhythmia, Type Outlook (Revenue - USD Billion, 2020 - 2034)
Supraventricular tachycardias
Ventricular
Bradyarrhythmias
Arrhythmia, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Russia
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
The introduction of technologically enhanced and innovative devices by the major players is driving the industry's growth. The industry's growth is likely to be aided by the development of technologically improved monitoring devices. Further, in July 2021, in the US, Abbott revealed Jot Dx, a new insertable cardiac monitor (ICM) designed to improve precise identification of difficult-to-detect irregular heart rhythms and reduce data burden. This technology allows for remote detection of cardiac arrhythmia and improves the accuracy of patient diagnosis.
Also, in March 2022, the ZOLL Arrhythmia Management System (AMS) from ZOLL Medical is a device that combines biometrics data with ECG data collected by typical mobile cardiac telemetry (MCT) devices. Over 60% of patients had their treatment plans changed once biometric data was added, including changes to lifestyle, drugs, and follow-up plans. Thus, these technologically advanced devices are boosting industry growth.
Based on the type, the tachycardia segment accounted for the leading share in the market. In the next years, the use of technologically enhanced solutions for disease monitoring is likely to boost demand for the tachycardia category. In 2021, atrial tachycardia accounted for the majority of the market and was predicted to continue to expand shortly.
It's a type of supraventricular tachycardia that needs to be treated aggressively for the best results. Cardiac-based devices serve an important role in improving illness detection and therapy. As a result of the rising risk of tachycardia, the cardiac market is expected to develop significantly shortly. Also, as per the CDC, around 40 Mn individuals in the U.S. still smoke, and 2.6 Mn school kids, including e-cigarette users. Every day, nearly 1,600 American teenagers under the age of 18 light up their 1st cigarette. Approximately 0.5 Mn people in the U.S. die prematurely each year. Another 16 million people suffer from a serious ailment as a result of smoking.
Market players such as Koninklijke Philips N.V., AliveCor, Biotronik, Biotricity, GE Healthcare, iRhythm Technologies, Medtronic plc., Nihon Kohden Corporation, St. Jude Medical (Abbott Laboratories), Spacelabs Healthcare (OSI Systems, Inc.), Applied Cardiac Systems, and Welch Allyn (Hillrom Services, Inc.) are some key players operating in the global market. In November 2021, Philips agreed to buy Cardiologs. This acquisition expands the company's cardiac monitoring and diagnostics product range, providing revenue growth potential in the industry.
Polaris Market Research has segmented the arrhythmia market report based on test equipment, site of origin atrial, type, and region:
Arrhythmia, Test Equipment Outlook (Revenue - USD Billion, 2020 - 2034)
Electrocardiogram (ECG)
Holter monitor
Arrhythmia, Site of Origin Atrial Outlook (Revenue - USD Billion, 2020 - 2034)
Sinus bradycardia
Premature atrial contractions (PACs)
Wandering atrial pacemaker
Atrial tachycardia
Multifocal atrial tachycardia
Supraventricular tachycardia (SVT)
Atrial flutter
Atrial fibrillation (Afib)
Arrhythmia, Type Outlook (Revenue - USD Billion, 2020 - 2034)
Supraventricular tachycardias
Ventricular
Bradyarrhythmias
Arrhythmia, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Spain
Netherlands
Russia
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
115 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
- 4. Global Organ-on-a-Chip Market Insights
- 4.1. Organ-on-a-Chip Market – Market Snapshot
- 4.2. Organ-on-a-Chip Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. The Demand for Safer and More Effective Drug Discovery
- 4.2.1.2. Push for Alternatives to Animal Testing
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High development cost and complexity
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Organ-on-a-Chip Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Organ-on-a-Chip Market, by Product and Services
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 5.3. Products
- 5.3.1. Global Organ-on-a-Chip Market, by Elements, by Region, 2020–2034 (USD Million)
- 5.3.2. Instrument
- 5.3.3. Devices
- 5.3.3.1. Liver-on-a-Chip
- 5.3.3.2. Lung-on-a-Chip
- 5.3.3.3. Intestine-on-a-Chip
- 5.3.3.4. Kidney-on-a-Chip
- 5.3.3.5. Heart-on-a-Chip
- 5.3.3.6. Others
- 5.4. Services
- 5.4.1. Global Organ-on-a-Chip Market, by Chemicals, by Region, 2020–2034 (USD Million)
- 6. Global Organ-on-a-Chip Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 6.3. Drug Discovery
- 6.3.1. Global Organ-on-a-Chip Market, by Drug Discovery, by Region, 2020–2034 (USD Million)
- 6.4. Toxicology Research
- 6.4.1. Global Organ-on-a-Chip Market, by Toxicology Research, by Region, 2020–2034 (USD Million)
- 6.5. Others
- 6.5.1. Global Organ-on-a-Chip Market, by Others, by Region, 2020–2034 (USD Million)
- 7. Global Organ-on-a-Chip Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 7.3. Academic & Research Institutes
- 7.3.1. Global Organ-on-a-Chip Market, by Academic & Research Institutes, by Region, 2020–2034 (USD Million)
- 7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Global Organ-on-a-Chip Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020–2034 (USD Million)
- 7.5. Others
- 7.5.1. Global Organ-on-a-Chip Market, by Others, by Region, 2020–2034 (USD Million)
- 8. Global Organ-on-a-Chip Market, by Geography
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Organ-on-a-Chip Market Assessment, By Geography, 2020–2034 (USD Million)
- 8.3. Organ-on-a-Chip Market – North America
- 8.3.1. North America: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.3.2. North America: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.3.3. North America: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.3.4. Organ-on-a-Chip Market – U.S.
- 8.3.4.1. U.S.: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.3.4.2. U.S.: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.3.4.3. U.S.: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.3.5. Organ-on-a-Chip Market – Canada
- 8.3.5.1. Canada: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.3.5.2. Canada: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.3.5.3. Canada: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4. Organ-on-a-Chip Market – Europe
- 8.4.1. Europe: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.2. Europe: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.3. Europe: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.4. Organ-on-a-Chip Market – UK
- 8.4.4.1. UK: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.4.2. UK: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.4.3. UK: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.5. Organ-on-a-Chip Market – France
- 8.4.5.1. France: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.5.2. France: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.5.3. France: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.6. Organ-on-a-Chip Market – Germany
- 8.4.6.1. Germany: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.6.2. Germany: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.6.3. Germany: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.7. Organ-on-a-Chip Market – Italy
- 8.4.7.1. Italy: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.7.2. Italy: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.7.3. Italy: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.8. Organ-on-a-Chip Market – Spain
- 8.4.8.1. Spain: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.8.2. Spain: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.8.3. Spain: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.9. Organ-on-a-Chip Market – Netherlands
- 8.4.9.1. Netherlands: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.9.2. Netherlands: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.9.3. Netherlands: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.10. Organ-on-a-Chip Market – Russia
- 8.4.10.1. Russia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.10.2. Russia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.10.3. Russia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.4.11. Organ-on-a-Chip Market – Rest of Europe
- 8.4.11.1. Rest of Europe: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.4.11.2. Rest of Europe: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.4.11.3. Rest of Europe: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5. Organ-on-a-Chip Market – Asia Pacific
- 8.5.1. Asia Pacific: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.2. Asia Pacific: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.3. Asia Pacific: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.4. Organ-on-a-Chip Market – China
- 8.5.4.1. China: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.4.2. China: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.4.3. China: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.5. Organ-on-a-Chip Market – India
- 8.5.5.1. India: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.5.2. India: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.5.3. India: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.6. Organ-on-a-Chip Market – Malaysia
- 8.5.6.1. Malaysia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.6.2. Malaysia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.6.3. Malaysia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.7. Organ-on-a-Chip Market – Japan
- 8.5.7.1. Japan: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.7.2. Japan: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.7.3. Japan: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.8. Organ-on-a-Chip Market – Indonesia
- 8.5.8.1. Indonesia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.8.2. Indonesia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.8.3. Indonesia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.9. Organ-on-a-Chip Market – South Korea
- 8.5.9.1. South Korea: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.9.2. South Korea: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.9.3. South Korea: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.10. Organ-on-a-Chip Market – Australia
- 8.5.10.1. Australia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.10.2. Australia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.10.3. Australia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.5.11. Organ-on-a-Chip Market – Rest of Asia Pacific
- 8.5.11.1. Rest of Asia Pacific: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.5.11.2. Rest of Asia Pacific: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.5.11.3. Rest of Asia Pacific: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6. Organ-on-a-Chip Market – Middle East & Africa
- 8.6.1. Middle East & Africa: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.2. Middle East & Africa: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.3. Middle East & Africa: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.4. Organ-on-a-Chip Market – Saudi Arabia
- 8.6.4.1. Saudi Arabia: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.4.2. Saudi Arabia: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.4.3. Saudi Arabia: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.5. Organ-on-a-Chip Market – UAE
- 8.6.5.1. UAE: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.5.2. UAE: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.5.3. UAE: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.6. Organ-on-a-Chip Market – Israel
- 8.6.6.1. Israel: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.6.2. Israel: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.6.3. Israel: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.7. Organ-on-a-Chip Market – South Africa
- 8.6.7.1. South Africa: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.7.2. South Africa: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.7.3. South Africa: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.6.8. Organ-on-a-Chip Market – Rest of Middle East & Africa
- 8.6.8.1. Rest of Middle East & Africa: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.6.8.2. Rest of Middle East & Africa: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.6.8.3. Rest of Middle East & Africa: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7. Organ-on-a-Chip Market – Latin America
- 8.7.1. Latin America: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.2. Latin America: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.3. Latin America: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7.4. Organ-on-a-Chip Market – Mexico
- 8.7.4.1. Mexico: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.4.2. Mexico: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.4.3. Mexico: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7.5. Organ-on-a-Chip Market – Brazil
- 8.7.5.1. Brazil: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.5.2. Brazil: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.5.3. Brazil: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7.6. Organ-on-a-Chip Market – Argentina
- 8.7.6.1. Argentina: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.6.2. Argentina: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.6.3. Argentina: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 8.7.7. Organ-on-a-Chip Market – Rest of Latin America
- 8.7.7.1. Rest of Latin America: Organ-on-a-Chip Market, by Product and Services, 2020–2034 (USD Million)
- 8.7.7.2. Rest of Latin America: Organ-on-a-Chip Market, by Application, 2020–2034 (USD Million)
- 8.7.7.3. Rest of Latin America: Organ-on-a-Chip Market, by End Use, 2020–2034 (USD Million)
- 9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
- 10. Company Profiles
- 10.1. AxoSim, Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. CN Bio Innovations Ltd.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Emulate, Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Hesperos, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Hµrel Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. InSphero AG
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. MIMETAS BV
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Nortis, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Tara Biosystems, Inc. (Charles River Laboratories)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. TissUse GmbH
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.